Atorvastatin leads to altered mononuclear cell gene expression prior to changes in serum low density cholesterol and triglyceride levels

被引：0
|
作者：
Haskard, DO
Berlaimont, V
Mandryko, V
Naoumova, R
Randi, A
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England
[2] GlaxoSmithKline, Stevenage, Herts, England
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
508
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 45 条
  • [41] Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities
    Department of Medical Biochemistry, Danish Ctr. for Hum. Genome Research, University of Aarhus, Aarhus, Denmark
    不详
    不详
    不详
    Electrophoresis, 2 (355-361):
  • [42] Significantly higher serum high-density lipoprotein cholesterol (HDL-C) levels in ankylosing spondylitis (AS) versus control (CN) patients: Correlations in the AS patients with non-smoking status (N-SS); low serum triglyceride (TG) levels, and clinical indicators of more advanced axial involvement.
    Masi, AT
    Mohan, PC
    Murugan, TSR
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S94 - S94
  • [43] IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment
    Morihara, Daisuke
    Ko, Yi-Ling
    Shibata, Kumiko
    Yamauchi, Ryo
    Fukuda, Hiromi
    Tsuchiya, Naoaki
    Fukunaga, Atsushi
    Kunimoto, Hideo
    Iwashita, Hideyuki
    Takata, Kazuhide
    Tanaka, Takashi
    Sakurai, Kunitoshi
    Inomata, Shinjiro
    Yokoyama, Keiji
    Nishizawa, Shinya
    Takeyama, Yasuaki
    Irie, Makoto
    Shakado, Satoshi
    Sohda, Tetsuro
    Sakisaka, Shotaro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 2019 - 2027
  • [44] Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: A 4-month, prospective, open-label, randomized, blinded-end point (Probe) trial
    Bevilacqua, M
    Guazzini, B
    Righini, V
    Barrella, M
    Toscano, R
    Chebat, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (04): : 330 - 344
  • [45] Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression
    Ness, GC
    Lopez, D
    Chambers, CM
    Newsome, WP
    Cornelius, P
    Long, CA
    Harwood, HJ
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (01) : 121 - 129
12345